rs1057518644
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs148881970
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs1553920379
|
|
AAAGT |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs1555582065
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs1566785444
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs387906846
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs529855742
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs555145190
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs587776625
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs606231193
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs875989800
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs879253767
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs104893877
|
|
|
0.040 |
GeneticVariation |
BEFREE |
Thus, expression of A</span>53T mutant human alpha-synuclein in mice results in adult-onset hyperactivity associated with D1 receptor and dopamine transporter-mediated alterations in dopamine neurotransmission.
|
16230020 |
2006 |
rs104895321
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Hyper-IgD and periodic fever syndrome: a new MVK mutation (p.R277G) associated with a severe phenotype.
|
24656624 |
2014 |
rs104895358
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Hyper-IgD and periodic fever syndrome (HIDS) due to compound heterozygosity for G336S and V377I in a 44-year-old patient with a 27-year history of fever.
|
27899390 |
2016 |
rs28934897
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Hyper-IgD and periodic fever syndrome (HIDS) due to compound heterozygosity for G336S and V377I in a 44-year-old patient with a 27-year history of fever.
|
27899390 |
2016 |
rs397507548
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Gln506Pro is predicted, by modeling analysis, to seriously disrupt the normal contacts between the regulating N-SH2 and the active PTP domains, leading to hyperactivity of the phosphatase.
|
14961557 |
2003 |
rs397509345
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Gln506Pro is predicted, by modeling analysis, to seriously disrupt the normal contacts between the regulating N-SH2 and the active PTP domains, leading to hyperactivity of the phosphatase.
|
14961557 |
2003 |
rs5569
|
|
|
0.010 |
GeneticVariation |
BEFREE |
A significant association was found between norepinephrine transporter gene G1287A genotypes and response to methylphenidate for hyperactive-impulsive subscale scores (mean score reduction was 7.15 and 6.94 for G/G and G/A genotype, respectively, and 2.13 for A/A; p = .012) but not inattentive scores.
|
15322419 |
2004 |
rs6191
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Additionally, both the rs6191 and rs25531 SNPs were significantly associated with the attention deficit factor (P = 0.006, P = 0.003, respectively) but not with the hyperactivity/impulsivity factor in the Swanson, Nolan and Pelham-IV Questionnaire (SNAP-IV) scale.
|
30707907 |
2019 |
rs25531
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Additionally, both the rs6191 and rs25531 SNPs were significantly associated with the attention deficit factor (P = 0.006, P = 0.003, respectively) but not with the hyperactivity/impulsivity factor in the Swanson, Nolan and Pelham-IV Questionnaire (SNAP-IV) scale.
|
30707907 |
2019 |
rs402691
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Additionally, haplotype-based association analysis for two SNPs located in Intron 3 (rs402691) and Exon 6 (rs3745406) indicated a significant overall association of the PRKCG locus with the ADHD-hyperactive subscale scores in the combined and Caucasian samples, supporting the relation between impulsive behaviors and the PRKCG gene.
|
17508994 |
2007 |
rs3745406
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Additionally, haplotype-based association analysis for two SNPs located in Intron 3 (rs402691) and Exon 6 (rs3745406) indicated a significant overall association of the PRKCG locus with the ADHD-hyperactive subscale scores in the combined and Caucasian samples, supporting the relation between impulsive behaviors and the PRKCG gene.
|
17508994 |
2007 |
rs113488022
|
|
|
0.040 |
GeneticVariation |
BEFREE |
Additionally, while over-expression of mutant BRAF(V600E) increased both Mcl-1L and Mcl-1S expression, inhibition of hyperactive BRAF signalling resulted in decreased Mcl-1L expression.
|
24118207 |
2013 |
rs121913377
|
|
|
0.040 |
GeneticVariation |
BEFREE |
Additionally, while over-expression of mutant BRAF(V600E) increased both Mcl-1L and Mcl-1S expression, inhibition of hyperactive BRAF signalling resulted in decreased Mcl-1L expression.
|
24118207 |
2013 |